Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Randomized Trial Comparing Short Course Androgen Deprivation Therapy and Ultra-Hypofractionated SBRT Versus SBRT Alone For Intermediate Prostate Cancer

NCT03056638 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.

NCT NCT03056638
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03056638 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Randomized Trial Comparing Short Course Androgen Deprivation Therapy and Ultra-Hypofractionated SBRT Versus SBRT Alone For Intermediate Prostate Cancer
Lead sponsor
Memorial Sloan Kettering Cancer Center
Phase
Phase 3
Overall status
Terminated
Start date
March 28, 2017
Completion date
August 16, 2023
Enrollment
56 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer